A Risk-Adapted Approach to Acute GVHD Treatment: Are We There Yet?
Acute GVHD is an immunologic complication of allogeneic hematopoietic cell transplantation that can range from mild to life-threatening. Models to predict patients at risk of poor outcomes have been developed using both clinical and laboratory data, and the time to test these models in clinical trials has arrived. The authors summarize recent refinements to these models. [Bone Marrow Transplant] Abstract

Visit our reviews page to see a complete list of reviews in the cord blood research field.